Reaction Details Report a problem with these data
Target
Uracil-DNA glycosylase
Ligand
BDBM208035
Substrate
n/a
Meas. Tech.
Viral Plaque Reduction Assay
Temperature
310.15±n/a K
IC50
86000±n/a nM
Comments
extracted
Citation
 Ricciardi, RP; Nuth, M Potent poxvirus inhibitor US Patent  US9233921 Publication Date 1/12/2016 
Target
Name:
Uracil-DNA glycosylase
Synonyms:
OPG116 | UNG | UNG_VACCC | vaccinia virus D4/A20
Type:
n/a
Mol. Mass.:
25083.53
Organism:
Vaccinia virus (strain Copenhagen) (VACV)
Description:
P20536
Residue:
218
Sequence:
MNSVTVSHAPYTITYHDDWEPVMSQLVEFYNEVASWLLRDETSPIPDKFFIQLKQPLRNKRVCVCGIDPYPKDGTGVPFESPNFTKKSIKEIASSISRLTGVIDYKGYNLNIIDGVIPWNYYLSCKLGETKSHAIYWDKISKLLLQHITKHVSVLYCLGKTDFSNIRAKLESPVTTIVGYHPAARDRQFEKDRSFEIINVLLELDNKVPINWAQGFIY
  
Inhibitor
Name:
BDBM208035
Synonyms:
3-((4-Chlorophenyl)thio)-1-ethyl-5-methyl-1H-indole-2-carboxylic acid | US9233921, 3
Type:
Small organic molecule
Emp. Form.:
C18H16ClNO2S
Mol. Mass.:
345.843
SMILES:
CCn1c(C(O)=O)c(Sc2ccc(Cl)cc2)c2cc(C)ccc12
Structure:
Search PDB for entries with ligand similarity: